Related Experiment Video
Updated: May 3, 2026
09:17
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
927
siRNA Delivery from an Injectable Scaffold for Wound Therapy
Christopher E Nelson1, Mukesh Kumar Gupta1, Elizabeth J Adolph2
1Department of Biomedical Engineering, Vanderbilt University , Nashville, Tennessee.
Advances in Wound Care
|February 15, 2014
Summary
This study introduces a novel nanoparticle-loaded polyurethane scaffold for delivering small interfering RNA (siRNA) to chronic wounds. This approach overcomes siRNA delivery barriers, offering a promising therapeutic strategy for enhanced wound healing.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Wound Healing Research
Background:
- Chronic skin wounds are often exacerbated by excessive inflammation.
- Small interfering RNA (siRNA) offers targeted gene silencing for therapeutic intervention.
- Existing siRNA delivery methods face challenges like degradation and poor cellular uptake.
Approach:
- Developed pH-responsive, siRNA-loaded nanoparticles.
- Incorporated nanoparticles into a biodegradable polyurethane (PUR) scaffold.
- The PUR scaffold is injectable and supports tissue regeneration.
Key Points:
- Nanoparticles protect siRNA and facilitate endosomal escape for cytosolic delivery.
- The PUR scaffold controls siRNA release kinetics for sustained therapeutic effect.
- This platform enables localized gene silencing in nonhealing wounds.
Conclusions:
- This novel siRNA delivery platform addresses critical barriers to in vivo gene silencing.
- It presents a potentially superior alternative to current growth factor therapies for wound care.
- The injectable, biodegradable scaffold offers a promising new option for clinicians treating chronic wounds.
